Evidence map›Paper›PMID 42184682›Full record

ArticleJournal of Ayurveda and integrative medicine

A recurrent hepatocellular carcinoma with incomplete response to conventional treatments, showing substantial regression and good quality of life by Ayurveda treatment: A case report.

Ranjit G Nimbalkar, Gayatri V Watpade, Anil T Pawar, Amol A Tagalpallewar, Akshay M Baheti, Manasi R Nimbalkar

Abstract readCase Reports
In one paragraph

Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ranjit G NimbalkarAyurved Practitioner, Anubandha Health Care, Tilak Road, Pune, India.
Gayatri V WatpadeSchool of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, India.
Anil T PawarSchool of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, India.
Amol A TagalpallewarSchool of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, India.
Akshay M BahetiSchool of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, India.
Manasi R NimbalkarDepartment of Kriya Sharir, Ashtang Ayurved Mahavidyalaya, Pune, India. Electronic address: manasi.dr@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma is a major global health concern with limited treatment options and high recurrence rates. This case study presents a 68-year-old male diagnosed with hepatocellular carcinoma who refused liver transplantation and underwent multiple conventional treatments, including Drug-eluting Bead trans-arterial chemoembolization (DEB TACE), targeted therapy, and radiation therapy. However, due to adverse effects and suspected disease progression, the patient opted to switch to Ayurvedic management. ,It incorporated Ayurvedic formulations, like suvarnamalinivasanta, phalatrikadiguggulu, patola, bhumyamalaki, and bhringaraja to support liver function, enhance immune response, and mitigate tumor progression. Over the course of treatment, the patient demonstrated improvements in clinical and biochemical parameters, including a reductions in alpha-fetoprotein and bilirubin levels, clinically improved liver function, enhanced physical strength, and better quality of life. Radiological assessments indicated disease stabilization with no significant metabolic activity. The case highlights the potential of an integrative approach to improve patient outcomes, particularly in those who decline or are unfit for liver transplantation.

Indexed as

AyurvedaBhumyamalakiHepatocellular carcinomaIntegrative medicineLiver disease managementSuvarnamalini vasant

Identifiers

PMID42184682
PMCPMC13226818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.